ACTILYSE 50 MG 2 VIALS+2 SOLVENTS I.V. INF

سعر ACTILYSE 50 MG 2 VIALS+2 SOLVENTS I.V. INF
10600.00 جنية
الشركة المنتجة لـ ACTILYSE 50 MG 2 VIALS+2 SOLVENTS I.V. INF
BOEHRINGER INGELHEIM
المادة الفعالة ACTILYSE 50 MG 2 VIALS+2 SOLVENTS I.V. INF
ALTEPLASE
معلومات عن ACTILYSE 50 MG 2 VIALS+2 SOLVENTS I.V. INF
ACTIVASE IS A TISSUE PLASMINOGEN ACTIVATOR (TPA)
INDICATIONS AND USAGE:
*ACUTE ISCHEMIC STROKE
EXCLUDE INTRACRANIAL HEMORRHAGE AS THE PRIMARY CAUSE OF STROKE SIGNS AND SYMPTOMS PRIOR TO INITIATION OF TREATMENT . INITIATE TREATMENT AS SOON AS POSSIBLE BUT WITHIN 3 HOURS AFTER SYMPTOM ONSET.
*ACUTE MYOCARDIAL INFARCTION
IT IS INDICATED FOR USE IN ACUTE MYOCARDIAL INFARCTION (AMI) FOR THE REDUCTION OF MORTALITY AND REDUCTION OF THE INCIDENCE OF HEART FAILURE.
LIMITATION OF USE: THE RISK OF STROKE MAY OUTWEIGH THE BENEFIT PRODUCED BY THROMBOLYTIC THERAPY IN PATIENTS WHOSE AMI PUTS THEM AT LOW RISK FOR DEATH OR HEART FAILURE.
*PULMONARY EMBOLISM
IT IS INDICATED FOR THE LYSIS OF ACUTE MASSIVE PULMONARY EMBOLISM DEFINED AS:
ACUTE PULMONARY EMBOLI OBSTRUCTING BLOOD FLOW TO A LOBE OR MULTIPLE LUNG SEGMENTS.
ACUTE PULMONARY EMBOLI ACCOMPANIED BY UNSTABLE HEMODYNAMICS E.G. FAILURE TO MAINTAIN BLOOD PRESSURE WITHOUT SUPPORTIVE MEASURES.